These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27039718)

  • 1. Effects of TNFα, NOS3, MDR1 Gene Polymorphisms on Clinical Parameters, Prognosis and Survival of Multiple Myeloma Cases.
    Basmaci C; Pehlivan M; Tomatir A; Sever T; Okan V; Yilmaz M; Oguzkan-Balci S; Pehlivan S
    Asian Pac J Cancer Prev; 2016; 17(3):1009-14. PubMed ID: 27039718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic role of TNF alpha, LT alpha, MDR1 and codon 72 Tp53 gene polymorphisms on multiple myeloma Egyptian patients.
    Hegazi HM; Elghonemy MS; El-Baiomy MA; Soliman EA; Abdel-Hady EK
    Leuk Res; 2022 Jun; 117():106854. PubMed ID: 35594781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population.
    Branković A; Brajušković G; Nikolić Z; Vukotić V; Cerović S; Savić-Pavićević D; Romac S
    Int J Exp Pathol; 2013 Dec; 94(6):355-61. PubMed ID: 23998439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the NOS3 intron-4 VNTR polymorphism with aneurysmal subarachnoid hemorrhage.
    Staalsø JM; Edsen T; Kotinis A; Romner B; Springborg JB; Olsen NV
    J Neurosurg; 2014 Sep; 121(3):587-92. PubMed ID: 24972130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.
    Kasamatsu T; Saitoh T; Ino R; Gotoh N; Mitsui T; Shimizu H; Matsumoto M; Sawamura M; Yokohama A; Handa H; Tsukamoto N; Murakami H
    Hematol Oncol; 2017 Dec; 35(4):711-718. PubMed ID: 27405747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G894T and 4a/b polymorphisms of NOS3 gene are not associated with cancer risk: a meta-analysis.
    Haque S; Mandal RK; Akhter N; Panda AK; Hussain A; Khan S; Lohani M
    Asian Pac J Cancer Prev; 2015; 16(7):2929-37. PubMed ID: 25854385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the TNF-α promoter polymorphisms for development of multiple myeloma and clinical outcome in thalidomide plus dexamethasone.
    Du J; Yuan Z; Zhang C; Fu W; Jiang H; Chen B; Hou J
    Leuk Res; 2010 Nov; 34(11):1453-8. PubMed ID: 20122728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of NOS3 gene polymorphisms with essential hypertension in Sudanese patients: a case control study.
    Gamil S; Erdmann J; Abdalrahman IB; Mohamed AO
    BMC Med Genet; 2017 Nov; 18(1):128. PubMed ID: 29132319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.
    Xiao Z; Yin G; Ni Y; Qu X; Wu H; Lu H; Qian S; Chen L; Li J; Qiu H; Miao K
    Biomed Pharmacother; 2017 Nov; 95():743-748. PubMed ID: 28888211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOS3 Gene rs1799983 and rs2070744 Polymorphisms in Patients with Unstable Angina.
    Pawlik A; Błaszczyk H; Rać M; Maciejewska-Skrendo A; Safranow K; Dziedziejko V
    J Vasc Res; 2020; 57(3):136-142. PubMed ID: 32224624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
    Ryk C; Koskela LR; Thiel T; Wiklund NP; Steineck G; Schumacher MC; de Verdier PJ
    Redox Biol; 2015 Dec; 6():272-277. PubMed ID: 26298202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of
    Chavoshi R; Khalifeh Zadeh Kaleybar SB
    Horm Mol Biol Clin Investig; 2020 Jun; 41(4):. PubMed ID: 32598309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship Between Endothelial Nitric Oxide Synthase Gene (NOS3) Polymorphisms, NOS3 Expression, and Varicocele.
    Kahraman CY; Tasdemir S; Sahin I; Marzioglu Ozdemir E; Yaralı O; Ziypak T; Adanur S; Kahraman M; Tatar A
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):191-6. PubMed ID: 26866567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of NOS2 and NOS3 gene polymorphisms with susceptibility to type 2 diabetes mellitus and diabetic nephropathy in the Chinese Han population.
    Chen F; Li YM; Yang LQ; Zhong CG; Zhuang ZX
    IUBMB Life; 2016 Jul; 68(7):516-25. PubMed ID: 27192959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
    AlFadhli S; Mohammed EM; Al Shubaili A
    Ann Hum Biol; 2013 Jul; 40(4):368-75. PubMed ID: 23826716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.
    Davies FE; Rollinson SJ; Rawstron AC; Roman E; Richards S; Drayson M; Child JA; Morgan GJ
    J Clin Oncol; 2000 Aug; 18(15):2843-51. PubMed ID: 10920132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Association of genetic polymorphisms in endothelial nitric oxide synthase 3 gene with recurrent early spontaneous abortion].
    Fan W; Li SW; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):23-6. PubMed ID: 17285538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ABCB1 T-129C polymorphism and multiple myeloma risk in Polish population.
    Niebudek K; Balcerczak E; Mirowski M; Żebrowska M
    Pol J Pathol; 2018; 69(4):405-409. PubMed ID: 30786691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the NOS3 gene in Tunisian patients with Behçet's disease.
    Kallel A; Sbaï MH; Houman MH; Sediri Y; Ouertani D; Smiti Khanfir M; Ben Ghorbel I; Jemaa R; Kaabachi N
    Int J Immunogenet; 2015 Apr; 42(2):87-92. PubMed ID: 25639851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional G894T (rs1799983) polymorphism and intron-4 VNTR variant of nitric oxide synthase (NOS3) gene are susceptibility biomarkers of obesity among Tunisians.
    Nasr HB; Dimassi S; M'hadhbi R; Debbabi H; Kortas M; Tabka Z; Chahed K
    Obes Res Clin Pract; 2016; 10(4):465-75. PubMed ID: 25956856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.